Chk1 inhibition with the Chk1-specific inhibitor prexasertib (LY2606368) exacerbated the anti-tumor effects of radiotherapy and suppressed RT-activated G1–S and G2–M checkpoint activation, allowing for DNA replication and mitosis to take place uninhibited. This evidence concerns the gene CHEK1 and neoplasm.